These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25171494)

  • 1. Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion.
    Furman MJ; Picotte RJ; Wante MJ; Rajeshkumar BR; Whalen GF; Lambert LA
    J Surg Oncol; 2014 Dec; 110(8):970-5. PubMed ID: 25171494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model.
    Ortega-Deballon P; Facy O; Magnin G; Piard F; Chauffert B; Rat P
    Eur J Surg Oncol; 2010 Mar; 36(3):324-8. PubMed ID: 19959323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer.
    Gervais MK; Dubé P; McConnell Y; Drolet P; Mitchell A; Sideris L
    J Surg Oncol; 2013 Dec; 108(7):438-43. PubMed ID: 24018983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system.
    Sánchez-García S; Padilla-Valverde D; Villarejo-Campos P; Martín-Fernández J; García-Rojo M; Rodríguez-Martínez M
    Surgery; 2014 Apr; 155(4):719-25. PubMed ID: 24502804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
    BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
    Zeamari S; Floot B; van der Vange N; Stewart FA
    Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia.
    Pelz JO; Vetterlein M; Grimmig T; Kerscher AG; Moll E; Lazariotou M; Matthes N; Faber M; Germer CT; Waaga-Gasser AM; Gasser M
    Ann Surg Oncol; 2013 Apr; 20(4):1105-13. PubMed ID: 23456378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study.
    Facy O; Al Samman S; Magnin G; Ghiringhelli F; Ladoire S; Chauffert B; Rat P; Ortega-Deballon P
    Ann Surg; 2012 Dec; 256(6):1084-8. PubMed ID: 22634898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
    Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
    In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
    Ceelen WP; Peeters M; Houtmeyers P; Breusegem C; De Somer F; Pattyn P
    Ann Surg Oncol; 2008 Feb; 15(2):535-41. PubMed ID: 17960463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
    Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
    Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea.
    Esquivel J
    Cancer J; 2009; 15(3):249-54. PubMed ID: 19556912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal drugs for HIPEC in different tumors.
    de Bree E
    J BUON; 2015 May; 20 Suppl 1():S40-6. PubMed ID: 26051331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
    Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
    Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.
    Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
    Br J Surg; 2010 Dec; 97(12):1874-80. PubMed ID: 20806291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.
    Turaga K; Levine E; Barone R; Sticca R; Petrelli N; Lambert L; Nash G; Morse M; Adbel-Misih R; Alexander HR; Attiyeh F; Bartlett D; Bastidas A; Blazer T; Chu Q; Chung K; Dominguez-Parra L; Espat NJ; Foster J; Fournier K; Garcia R; Goodman M; Hanna N; Harrison L; Hoefer R; Holtzman M; Kane J; Labow D; Li B; Lowy A; Mansfield P; Ong E; Pameijer C; Pingpank J; Quinones M; Royal R; Salti G; Sardi A; Shen P; Skitzki J; Spellman J; Stewart J; Esquivel J
    Ann Surg Oncol; 2014 May; 21(5):1501-5. PubMed ID: 23793364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
    Glockzin G; von Breitenbuch P; Schlitt HJ; Piso P
    J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
    Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
    Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.